CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

February 14, 2022 · earnings

ROIV earnings: a positive outcome, +5.1%

On February 14, 2022, Roivant Sciences Ltd. reached its earnings. The result was a positive outcome, and the stock moved +5.1% in the window around the event. It had already run -13.8% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$6.85
1d before
$7.20
Event day
$7.22
1d after
$6.63
5d after

Pre-catalyst setup

-13.8%
30-day run-up
5143%
30-day volatility
1.0×
volume spike